264 related articles for article (PubMed ID: 22783055)
21. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
[TBL] [Abstract][Full Text] [Related]
22. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
[TBL] [Abstract][Full Text] [Related]
23. CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer.
Kang JM; Lee BH; Kim N; Lee HS; Lee HE; Park JH; Kim JS; Jung HC; Song IS
J Korean Med Sci; 2011 May; 26(5):647-53. PubMed ID: 21532856
[TBL] [Abstract][Full Text] [Related]
24. HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.
Fusco N; Rocco EG; Del Conte C; Pellegrini C; Bulfamante G; Di Nuovo F; Romagnoli S; Bosari S
Mod Pathol; 2013 Jun; 26(6):816-24. PubMed ID: 23348899
[TBL] [Abstract][Full Text] [Related]
25. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter PyloriAssociation with Expression of CDX2 in Intestinal Metaplasia.
Malik TH; WangYu ; XuHong
J Coll Physicians Surg Pak; 2017 Nov; 27(11):678-681. PubMed ID: 29132476
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
Xiong ZF; Xiao H; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.
Lin CK; Lai KH; Lo GH; Cheng JS; Hsu PI; Mok KT; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):331-6. PubMed ID: 11534800
[TBL] [Abstract][Full Text] [Related]
29. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications.
Seno H; Oshima M; Taniguchi MA; Usami K; Ishikawa TO; Chiba T; Taketo MM
Int J Oncol; 2002 Oct; 21(4):769-74. PubMed ID: 12239615
[TBL] [Abstract][Full Text] [Related]
30. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
[TBL] [Abstract][Full Text] [Related]
31. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
32. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
[TBL] [Abstract][Full Text] [Related]
33. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.
Zhao DQ; Chen J; Wu YF; Tian D; Zhou RX
Hepatogastroenterology; 2014 Jun; 61(132):1154-8. PubMed ID: 26158180
[TBL] [Abstract][Full Text] [Related]
34. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
35. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
[TBL] [Abstract][Full Text] [Related]
36. Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype.
Cassaro M; Rugge M; Tieppo C; Giacomelli L; Velo D; Nitti D; Farinati F
J Clin Pathol; 2007 Jun; 60(6):615-21. PubMed ID: 17557866
[TBL] [Abstract][Full Text] [Related]
37. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer.
Okayama H; Kumamoto K; Saitou K; Hayase S; Kofunato Y; Sato Y; Miyamoto K; Nakamura I; Ohki S; Sekikawa K; Takenoshita S
Oncol Rep; 2009 Oct; 22(4):745-55. PubMed ID: 19724852
[TBL] [Abstract][Full Text] [Related]
38. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
[TBL] [Abstract][Full Text] [Related]
39. [Expression and significance of caudal type transcription factor-2 in gastric mucosa at different stages of gastric carcinogenesis].
Chen HX; Chen MH; Song X
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):247-9. PubMed ID: 16677504
[TBL] [Abstract][Full Text] [Related]
40. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.
Bai YQ; Yamamoto H; Akiyama Y; Tanaka H; Takizawa T; Koike M; Kenji Yagi O; Saitoh K; Takeshita K; Iwai T; Yuasa Y
Cancer Lett; 2002 Feb; 176(1):47-55. PubMed ID: 11790453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
